FDA — authorised 30 July 2010
- Application: BLA125360
- Marketing authorisation holder: MERZ PHARMS
- Local brand name: Xeomin
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Xeomin in United States
FDA authorised Xeomin on 30 July 2010
Marketing authorisations
FDA
- Marketing authorisation holder: MERZ PHARMS
- Status: approved
Xeomin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Xeomin approved in United States?
Yes. FDA authorised it on 30 July 2010; FDA has authorised it.
Who is the marketing authorisation holder for Xeomin in United States?
MERZ PHARMS holds the US marketing authorisation.